PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Oct-2024 OccuPro Launches POET 4.0: Revolutionary Upgrade to Post Offer Employment Testing Software AccessWire
01-Oct-2024 New Report: Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome AccessWire
01-Oct-2024 Heidelberg Pharma AG Announces Updated Guidance Heidelberg Pharma AG
01-Oct-2024 Lexaria Appoints Michael Shankman as Chief Financial Officer AccessWire
01-Oct-2024 Kyowa Kirin Presents Real-World Evidence Demonstrating Clinically Meaningful Impact of Burosumab Treatment in Adults with X-linked Hypophosphatemia Kyowa Kirin
01-Oct-2024 Helios Global Group, a leading full-service global healthcare communications provider, announces next stage of investment by Telemos Capital to support ambitious future growth Helios Global Group
01-Oct-2024 Galapagos receives transparency notification from EcoR1 Capital Galapagos
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 CSL Behring granted positive reimbursement recommendation for Haemophilia B Gene Therapy, HEMGENIX® in Spain CSL
01-Oct-2024 Abzena Expands Partnership with ProteoNic to Include 2G UNic® Technology as Standard Offering for All Customers ProteoNic
01-Oct-2024 AlzeCure's abstract on ACD856's anti-inflammatory effects to be presented at a leading Alzheimer's conference AlzeCure Pharma AB (publ)
01-Oct-2024 Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US AccessWire
01-Oct-2024 AstronauTx appoints Jane Rhodes as Chief Executive Officer and Expands Executive Team AstronauTx Ltd
01-Oct-2024 Neuraxpharm expands operations into the Middle East Neuraxpharm
01-Oct-2024 Nxera Pharma Enters New Commercial Partnership with Shionogi for QUVIVIQ™ in Japan Nxera Pharma
01-Oct-2024 Santhera Announces Positive Topline Results from LIONHEART Study with AGAMREE® (vamorolone) Demonstrating Unique Mineralocorticoid Receptor Antagonism Santhera Pharmaceuticals
01-Oct-2024 Nxera Pharma Appoints Experienced Commercial R&D Executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan Nxera Pharma
01-Oct-2024 Tessellate BIO, Omico and CMRI announce a multi-year collaboration to accelerate discovery of synthetic lethal precision therapies to address ‘ALT’ cancers Tessellate BIO
01-Oct-2024 Celadon Pharmaceuticals Plc Departure of Chief Financial Officer